House Speaker Nancy Pelosi was right last week when she called her latest health-care-reform proposal a “his toric moment”: After decades of life-saving and cost-cutting scientific innovations from drug and medical-device companies, the government is about to step in and stifle the R&D that is our best hope for improving health outcomes.
Pelosi’s bill may cost pharmaceutical companies $150 billion over a decade — nearly double the amount they conceded when they cut a White House-approved deal with Sen. Max Baucus this summer.
The Pelosi bill is a prescription for fewer new life-saving drugs. By stifling innovation, it would hurt not only industry, but also all of us who’d benefit from new-drug development.
Read the whole thing. Somehow, we are supposed to believe that less access to life-saving drugs is supposed to be a good thing.